Saffron has been cultivated and valued for over three thousand years across Greece and Southwest Asia, prized both as the world's most expensive spice by weight and as a traditional medicine used across Persian, Greek, and later broader Mediterranean and South Asian herbal systems for mood and general health complaints.
Saffron's modern research reputation has developed into one of the more scientifically substantiated traditional mood remedies in this Atlas, with a genuinely notable body of trials directly comparing it to prescription antidepressant medications.
Saffron has an unusually strong and consistent evidence base for depression, replicated across multiple independent meta-analyses. A comprehensive 2025 meta-analysis directly comparing saffron to SSRIs across 8 studies found no significant difference between saffron and standard antidepressant medication in reducing depressive symptoms — meaning saffron performed comparably to prescription drugs — with saffron users experiencing fewer adverse effects. A well-designed 202-person randomized controlled trial found saffron significantly improved depression scores compared to placebo, with 72.3% achieving clinically significant improvement versus 54.3% on placebo.
Saffron's supporting evidence was strong enough that a formal psychiatric treatment guideline assigned it "Grade A evidence" for unipolar depression, placing it alongside St. John's Wort, curcumin, and lavender. The honest nuance: one recent trial specifically in people with subclinical depressive symptoms found no significant effect on individual measures, suggesting benefit may be clearer in diagnosed depression than milder presentations. Given multiple independent meta-analyses and formal guideline recognition, "Moderate-Strong" is the accurate rating.
Dried stigmas used whole or ground into powder, traditionally steeped in warm water or milk, or used as a culinary spice and coloring agent.